These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23179890)

  • 21. Recent advances in hybrid molecular imaging systems.
    Lee JS; Kim JH
    Semin Musculoskelet Radiol; 2014 Apr; 18(2):103-22. PubMed ID: 24715444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal imaging approaches: PET/CT and PET/MRI.
    Pichler BJ; Judenhofer MS; Pfannenberg C
    Handb Exp Pharmacol; 2008; (185 Pt 1):109-32. PubMed ID: 18626801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A decade of multi-modality PET and MR imaging in abdominal oncology.
    Min LA; Castagnoli F; Vogel WV; Vellenga JP; van Griethuysen JJM; Lahaye MJ; Maas M; Beets Tan RGH; Lambregts DMJ
    Br J Radiol; 2021 Oct; 94(1126):20201351. PubMed ID: 34387508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
    Runge VM
    Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
    Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
    Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in microscopy and complementary imaging techniques to assess the fate of drugs ex vivo in respiratory drug delivery: an invited paper.
    Park CW; Rhee YS; Vogt FG; Hayes D; Zwischenberger JB; DeLuca PP; Mansour HM
    Adv Drug Deliv Rev; 2012 Mar; 64(4):344-56. PubMed ID: 21920394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging: an overview and clinical applications.
    Rollo FD
    Radiol Manage; 2003; 25(3):28-32; quiz 33-5. PubMed ID: 12817419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality molecular imaging with combined optical and SPECT/PET modalities.
    Culver J; Akers W; Achilefu S
    J Nucl Med; 2008 Feb; 49(2):169-72. PubMed ID: 18199608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathophysiology of dementia and medical imaging].
    Yonekura Y
    Rinsho Hoshasen; 1989 Oct; 34(11):1349-53. PubMed ID: 2601097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear medicine imaging of endocrine neoplasms.
    Wong KK; Kandathil A; Marzola MC; Gross MD; Rubello D
    Nucl Med Commun; 2014 Jan; 35(1):1-19. PubMed ID: 24201551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
    Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MP; Townsend DW; Berland LL; ; ;
    J Am Coll Radiol; 2005 Jul; 2(7):568-84. PubMed ID: 17411882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational Multimodality Neuroimaging.
    Sharma S
    Curr Drug Targets; 2017; 18(9):1039-1050. PubMed ID: 28302035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging the airways in 2006.
    Bailey DL
    J Aerosol Med; 2006; 19(1):1-7. PubMed ID: 16551209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning for radiomics-based multimodality and multiparametric modeling.
    Wei L; Osman S; Hatt M; El Naqa I
    Q J Nucl Med Mol Imaging; 2019 Dec; 63(4):323-338. PubMed ID: 31527580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality molecular imaging of the lung.
    Chen DL; Kinahan PE
    J Magn Reson Imaging; 2010 Dec; 32(6):1409-20. PubMed ID: 21105145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State of the art in vivo imaging techniques for laboratory animals.
    Lauber DT; Fülöp A; Kovács T; Szigeti K; Máthé D; Szijártó A
    Lab Anim; 2017 Oct; 51(5):465-478. PubMed ID: 28948893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives.
    Hahn MA; Singh AK; Sharma P; Brown SC; Moudgil BM
    Anal Bioanal Chem; 2011 Jan; 399(1):3-27. PubMed ID: 20924568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodality fusion imaging in abdominal and pelvic malignancies: current applications and future perspectives.
    Paparo F; Piccardo A; Bacigalupo L; Piccazzo R; Rollandi L; Galletto Pregliasco A; Filauro M; DeCensi A; Rollandi GA
    Abdom Imaging; 2015 Oct; 40(7):2723-37. PubMed ID: 25952574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.